243 related articles for article (PubMed ID: 9825878)
21. Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.
Hagiwara T; Mukaisho K; Nakayama T; Sugihara H; Hattori T
Gut; 2011 May; 60(5):624-30. PubMed ID: 21097844
[TBL] [Abstract][Full Text] [Related]
22. Acid secretion from birth to adulthood.
Boyle JT
J Pediatr Gastroenterol Nutr; 2003; 37 Suppl 1():S12-6. PubMed ID: 14685072
[TBL] [Abstract][Full Text] [Related]
23. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia.
Hassall E; Owen D; Kerr W; Sturby T; Richardson P; El-Serag H
Aliment Pharmacol Ther; 2011 Apr; 33(7):829-36. PubMed ID: 21320136
[TBL] [Abstract][Full Text] [Related]
24. Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions?
Eslami L; Nasseri-Moghaddam S
Arch Iran Med; 2013 Aug; 16(8):449-58. PubMed ID: 23906249
[TBL] [Abstract][Full Text] [Related]
25. Antiulcer drugs and gastric cancer.
Waldum HL; Gustafsson B; Fossmark R; Qvigstad G
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S39-44. PubMed ID: 16184420
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.
Anjiki H; Mukaisho KI; Kadomoto Y; Doi H; Yoshikawa K; Nakayama T; Vo DT; Hattori T; Sugihara H
Clin J Gastroenterol; 2017 Apr; 10(2):128-136. PubMed ID: 28160247
[TBL] [Abstract][Full Text] [Related]
27. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
Rew JS
Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
Savarino V; Di Mario F; Scarpignato C
Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
[TBL] [Abstract][Full Text] [Related]
29. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
30. Problems Associated with Deprescribing of Proton Pump Inhibitors.
Helgadottir H; Bjornsson ES
Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
[TBL] [Abstract][Full Text] [Related]
31. Review article: the use of gastric acid-inhibitory drugs--physiological and pathophysiological considerations.
Waldum HL; Brenna E; Kleveland PM; Sandvik AK; Syversen U
Aliment Pharmacol Ther; 1993 Dec; 7(6):589-96. PubMed ID: 7909240
[TBL] [Abstract][Full Text] [Related]
32. Formulary management of proton pump inhibitors.
Byrne MF; Murray FE
Pharmacoeconomics; 1999 Sep; 16(3):225-46. PubMed ID: 10558037
[TBL] [Abstract][Full Text] [Related]
33. Acid suppression therapy: where do we go from here?
Scarpignato C; Pelosini I; Di Mario F
Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitors and acid-related diseases.
Sachs G
Pharmacotherapy; 1997; 17(1):22-37. PubMed ID: 9017763
[TBL] [Abstract][Full Text] [Related]
35. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
Gisbert JP; Pajares JM; Losa C
Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
[TBL] [Abstract][Full Text] [Related]
37. Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?
Rauws EA
Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):569-73. PubMed ID: 9513835
[TBL] [Abstract][Full Text] [Related]
38. PPIs, H. pylori, and atrophic gastritis: putting the issue to rest?
DiBaise JK
Am J Gastroenterol; 1999 Dec; 94(12):3403. PubMed ID: 10606289
[No Abstract] [Full Text] [Related]
39. Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?
Yeomans ND; Dent J
Aliment Pharmacol Ther; 2000 Mar; 14(3):267-71. PubMed ID: 10735918
[TBL] [Abstract][Full Text] [Related]
40. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
